These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 9767722

  • 21. Combined vaccine against measles, mumps, rubella, and varicella.
    Brunell PA, Novelli VM, Lipton SV, Pollock B.
    Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743
    [Abstract] [Full Text] [Related]

  • 22. [Hemolytic and uremic syndrome after measles, mumps and rubella vaccination. Fortuitous association?].
    Tsimaratos M, Le Menestrel S, Daniel L, Roquelaure B, Almhana T, de Montléon JV, Paut O, Picon G, Casanova P, Sarles J.
    Arch Pediatr; 1997 Dec; 4(12):1261-2. PubMed ID: 9538434
    [No Abstract] [Full Text] [Related]

  • 23. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC, Burgess MA, Forrest JM.
    Commun Dis Intell; 1998 Aug 06; 22(8):157-8. PubMed ID: 9735550
    [No Abstract] [Full Text] [Related]

  • 24. Systemic reactions to measles-mumps-rubella vaccine skin testing.
    Puvvada L, Silverman B, Bassett C, Chiaramonte LT.
    Pediatrics; 1993 Apr 06; 91(4):835-6. PubMed ID: 8464677
    [No Abstract] [Full Text] [Related]

  • 25. Measles/mumps/rubella vaccine: a new start.
    Midwife Health Visit Community Nurse; 1988 Sep 06; 24(9):347, 359. PubMed ID: 3205171
    [No Abstract] [Full Text] [Related]

  • 26. [Certain problems with limits of immunity against measles, mumps and rubella].
    Magdzik W.
    Przegl Epidemiol; 1993 Sep 06; 47(1-2):47-53. PubMed ID: 8351387
    [Abstract] [Full Text] [Related]

  • 27. Measles, mumps, rubella vaccine administration in egg-sensitive children: systemic reactions during vaccine desensitization.
    Trotter AC, Stone BD, Laszlo DJ, Georgitis JW.
    Ann Allergy; 1994 Jan 06; 72(1):25-8. PubMed ID: 8291745
    [Abstract] [Full Text] [Related]

  • 28. [Incubation vaccination ("post-exposure vaccination") with MMR vaccine during a mumps epidemic? The Pediatric Vaccine Counseling Unit].
    Wiersbitzky S, Bruns R, Beyer B.
    Kinderarztl Prax; 1992 Oct 06; 60(7):207-8. PubMed ID: 1359187
    [No Abstract] [Full Text] [Related]

  • 29. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination.
    Vlacha V, Forman EN, Miron D, Peter G.
    Pediatrics; 1996 May 06; 97(5):738-9. PubMed ID: 8628619
    [No Abstract] [Full Text] [Related]

  • 30. [Is a second dose of the triple viral vaccine necessary?].
    Echevarría JM, de Ory F.
    Med Clin (Barc); 1997 Jun 28; 109(5):196-7. PubMed ID: 9289545
    [No Abstract] [Full Text] [Related]

  • 31. [Thrombocytopenic purpura after single or combined vaccination against measles, mumps and rubella].
    Autret E, Jonville-Béra AP, Galy-Eyraud C, Hessel L.
    Arch Pediatr; 1996 Apr 28; 3(4):393-4. PubMed ID: 8762965
    [No Abstract] [Full Text] [Related]

  • 32. National Advisory Committee on Immunization (NACI). Supplementary statement MMR vaccine and anaphylactic hypersensitivity to egg or egg-related antigens.
    Can Commun Dis Rep; 1996 Jul 15; 22(14):113-5. PubMed ID: 8754935
    [Abstract] [Full Text] [Related]

  • 33. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
    Watson BM, Laufer DS, Kuter BJ, Staehle B, White CJ, Starr SE.
    J Infect Dis; 1996 Mar 15; 173(3):731-4. PubMed ID: 8627041
    [Abstract] [Full Text] [Related]

  • 34. Measles-mumps-rubella immunisation, autism and inflammatory bowel disease: update.
    Amin J, Wong M.
    Commun Dis Intell; 1999 Aug 05; 23(8):222. PubMed ID: 10497836
    [No Abstract] [Full Text] [Related]

  • 35. [Increased risk of invasive bacterial infections after preventive mumps-measles-rubella vaccination?].
    Wiersbitzky S, Bruns R, Mentel R.
    Kinderarztl Prax; 1993 Jun 05; 61(4-5):170-1. PubMed ID: 8361148
    [No Abstract] [Full Text] [Related]

  • 36. [Infant with febrile convulsions/incidental convulsions in the history: how does one proceed with diphtheria-pertussis-tetanus (DPT) and mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S, Bruns R, Burtzlaff C.
    Kinderarztl Prax; 1993 Nov 05; 61(9):339-40. PubMed ID: 8114462
    [No Abstract] [Full Text] [Related]

  • 37. [Encephalitis, meningitis serosa and parotitis after MMR preventive vaccination? The Pediatric Vaccination Counseling Unit].
    Wiersbitzky S, Bruns R, Peters A, Mentel R.
    Kinderarztl Prax; 1992 Oct 05; 60(7):203-5. PubMed ID: 1359186
    [No Abstract] [Full Text] [Related]

  • 38. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 39. Measles, mumps, rubella vaccine: through a glass, darkly.
    Wakefield AJ, Montgomery SM.
    Adverse Drug React Toxicol Rev; 2000 Dec 28; 19(4):265-83; discussion 284-92. PubMed ID: 11212459
    [No Abstract] [Full Text] [Related]

  • 40. [Exanthema with high fever and cerebral seizure susceptibility after mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S, Bruns R, Mentel R.
    Kinderarztl Prax; 1993 Aug 28; 61(6):227-8. PubMed ID: 8105135
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.